Skip to Content
MilliporeSigma
All Photos(1)

Documents

OX-8 Cell Line from murine myeloma

Reactivity: Anti- CD8, rat, 84112009

Sign Into View Organizational & Contract Pricing


About This Item

UNSPSC Code:
41106514

biological source

Mouse x Mouse Hybridoma

ImmunoDon

BALB/c mouse spleen

Myeloma

NS1

Reactivity

Anti-CD8, rat

technique(s)

cell culture | mammalian: suitable

isotype

IgG1

shipped in

dry ice

storage temp.

−196°C

Related Categories

Cell Line Origin

Mouse NS1 x Mouse BALB/c spleen

Cell Line Description

The antibody recognises subset of rat peripheral T cells that possess suppresser and cytotoxic activities. antibody labels all peripheral T cells that are unlabelled by W3/25. 90% of thymocytes are labelled by both Antibodies. NK cells express the OX-8 antigen.

Immunogen

High molecular weight rat thymocyte glycoproteins

Culture Medium

RPMI 1640 + 2mM glutamine + 10% Foetal Bovine Serum (FBS)

Subculture Routine

Seed at 5x10,000 viable cells/ml. Subculture when cells reach 5x100,000-1x1,000,000 cells/ml (usually after 3-4 days); 5% CO2; 37°C.

Other Notes

Additional freight & handling charges may be applicable for Asia-Pacific shipments. Please check with your local Customer Service representative for more information.

Disclaimer

This cell line has special release conditions: Commercial organisations are required to complete the ′Cell Line Release Authorisation for Research Use in Commercial Organisations′ release conditions form.

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service